Cargando…
Implementation of Novel Affinity Ligand for Lentiviral Vector Purification
The use of viral vectors as therapeutic products for multiple applications such as vaccines, cancer treatment, or gene therapies, has been growing exponentially. Therefore, improved manufacturing processes are needed to cope with the high number of functional particles required for clinical trials a...
Autores principales: | Moreira, Ana Sofia, Bezemer, Sandra, Faria, Tiago Q., Detmers, Frank, Hermans, Pim, Sierkstra, Laurens, Coroadinha, Ana Sofia, Peixoto, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966744/ https://www.ncbi.nlm.nih.gov/pubmed/36834764 http://dx.doi.org/10.3390/ijms24043354 |
Ejemplares similares
-
Host Cell Restriction Factors Blocking Efficient Vector Transduction: Challenges in Lentiviral and Adeno-Associated Vector Based Gene Therapies
por: Coroadinha, Ana Sofia
Publicado: (2023) -
Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
por: Tomás, Hélio A., et al.
Publicado: (2019) -
Camelid V(H)H affinity ligands enable separation of closely related biopharmaceuticals
por: Pabst, Timothy M., et al.
Publicado: (2016) -
LentiPro26: novel stable cell lines for constitutive lentiviral vector production
por: Tomás, H. A., et al.
Publicado: (2018) -
Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies
por: Mietzsch, Mario, et al.
Publicado: (2020)